Liraglutide Exerts Antidiabetic Effect via PTP1B and PI3K/Akt2 Signaling Pathway in Skeletal Muscle of KKAy Mice

Background. Liraglutide (a glucagon-like peptide 1 analog) was used for the treatment of type 2 diabetes (T2DM) which could produce glucose-dependent insulin secretion. Aim. The aim was to investigate whether liraglutide could improve myofibril and mitochondria injury in skeletal muscle and the mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Wenjun, Chen, Xinlin, Lv, Juan, Wang, Meng, Ren, Shuting, Yuan, Bingxiang, Wang, Bing, Chen, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144308/
https://www.ncbi.nlm.nih.gov/pubmed/25183970
http://dx.doi.org/10.1155/2014/312452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144308/
https://www.ncbi.nlm.nih.gov/pubmed/25183970
http://dx.doi.org/10.1155/2014/312452

Ejemplares similares